Company

Marvel Biosciences Corp

Headquarters: Calgary, AB, Canada

CEO: Mr. J. Roderick Matheson

TSXV: MRVL -2.94%

Detailed Description

Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs that inhibit the A2a adenosine receptor. The company offers Nourianz (Istradefylline, KW-6002), an adenosine A2A receptor antagonist. It targets neurological diseases, such as Alzheimer's disease, depression and anxiety, and addictions; non-neurological conditions of cancer; and non-alcoholic steatohepatitis. Marvel Biosciences Corp. is headquartered in Calgary, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Marvel Biosciences Corp has the following listings and related stock indices.


Stock: TSXV: MRVL wb_incandescent

Details

Headquarters:

505 8th Avenue S.W.

Suit 420

Calgary, AB T2P 1G2

Canada

Phone: 403 770 2469